These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
713 related articles for article (PubMed ID: 34133854)
1. Treatment of Multisystem Inflammatory Syndrome in Children. McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M; N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854 [TBL] [Abstract][Full Text] [Related]
2. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG; N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855 [TBL] [Abstract][Full Text] [Related]
3. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F; JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study. Channon-Wells S; Vito O; McArdle AJ; Seaby EG; Patel H; Shah P; Pazukhina E; Wilson C; Broderick C; D'Souza G; Keren I; Nijman RG; Tremoulet A; Munblit D; Ulloa-Gutierrez R; Carter MJ; Ramnarayan P; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Blyuss O; Levin M; Lancet Rheumatol; 2023 Apr; 5(4):e184-e199. PubMed ID: 36855438 [TBL] [Abstract][Full Text] [Related]
5. Initial Immunomodulation and Outcome of Children with Multisystem Inflammatory Syndrome Related to COVID-19: A Multisite Study from India. Bagri NK; Khan M; Pandey RM; Lodha R; Kabra SK; Indian J Pediatr; 2022 Dec; 89(12):1236-1242. PubMed ID: 35699843 [TBL] [Abstract][Full Text] [Related]
6. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children. Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD Front Immunol; 2021; 12():632890. PubMed ID: 33732254 [TBL] [Abstract][Full Text] [Related]
9. Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review. Wang Z; Zhao S; Tang Y; Wang Z; Shi Q; Dang X; Gan L; Peng S; Li W; Zhou Q; Li Q; Mafiana JJ; Cortés RG; Luo Z; Liu E; Chen Y Eur J Pediatr; 2022 May; 181(5):2135-2146. PubMed ID: 35192051 [TBL] [Abstract][Full Text] [Related]
10. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals. Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S; Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394 [TBL] [Abstract][Full Text] [Related]
11. Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children. Chang JC; Young CC; Muscal E; Sexson Tejtel SK; Newhams MM; Kucukak S; Crandall H; Maddux AB; Rowan CM; Halasa NB; Harvey HA; Hobbs CV; Hall MW; Kong M; Aguiar CL; Schuster JE; Fitzgerald JC; Singh AR; Wellnitz K; Nofziger RA; Cvijanovich NZ; Mack EH; Schwarz AJ; Heidemann SM; Newburger JW; Zambrano LD; Campbell AP; Patel MM; Randolph AG; Son MBF; Arthritis Rheumatol; 2023 Aug; 75(8):1466-1476. PubMed ID: 36908050 [TBL] [Abstract][Full Text] [Related]
12. Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage. Vukomanovic V; Krasic S; Prijic S; Ninic S; Popovic S; Petrovic G; Ristic S; Simic R; Cerovic I; Nesic D Pediatr Infect Dis J; 2021 Nov; 40(11):e390-e394. PubMed ID: 34260481 [TBL] [Abstract][Full Text] [Related]
13. Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children. Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W; Chandrakasan S; Oster ME; Jaggi P; Prahalad S JAMA Pediatr; 2022 Jun; 176(6):576-584. PubMed ID: 35344042 [TBL] [Abstract][Full Text] [Related]
14. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511 [TBL] [Abstract][Full Text] [Related]
15. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A; Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806 [TBL] [Abstract][Full Text] [Related]
16. MIS-C Treatment: Is glucocorticoid monotherapy enough for mild cases? Sütçü M; Kara EM; Yıldız F; Gül D; Yıldız R; Yılmaz D; Atik F; Özkaya O Am J Emerg Med; 2024 Sep; 83():95-100. PubMed ID: 39002497 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment. Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570 [TBL] [Abstract][Full Text] [Related]
18. Treatment of multisystem inflammatory syndrome in children. Tong T; Jin YH; Wang M; Gong FQ World J Pediatr; 2024 Apr; 20(4):325-339. PubMed ID: 38509432 [TBL] [Abstract][Full Text] [Related]
19. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome. Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681 [TBL] [Abstract][Full Text] [Related]
20. Multisystem inflammatory syndrome in children: an Umbrella review. Shioji N; Sumie M; Englesakis M; Gilfoyle E; Maynes JT; Aoyama K J Anesth; 2024 Jun; 38(3):309-320. PubMed ID: 38530453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]